New Fat-Burning Diabetes Pill Protects Muscle and Appetite
The compound boosted energy expenditure and preserved muscle, and lower-dose combinations with semaglutide and tirzepatide worked better than either drug alone.
6 Articles
6 Articles
New fat-burning diabetes pill protects muscle and appetite
Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 drugs. Early trials suggest it improves blood sugar control and fat metabolism while preserving muscle mass, with fewer side effects. Because it acts through a different mechanism, it could be paired with GLP-1 treatments for even stronger results.
An experimental drug helps obese mice burn fat without losing muscle mass or having to eat less, a new approach that could offer an additional option for treating obesity.
Researchers at the University of California at Berkeley found that the TOFA compound increases energy spending on mice and reduces body fat without losing muscle mass, also improving metabolic health A team of scientists from the University of California – Berkeley discovered a new approach to treating obesity, using an experimental compound called 5-tetradecyloxy-2-furoic acid (TOFA).This compound, which had already been studied in the 1970s, p…
The experimental drug helped obese mice burn more fat, at the same time the animals did not start eating less. In four weeks, they lost an average of 18% of their weight.
Substance caused rats to lose fat even without reducing ingested food, with increased energy expenditure and preservation of muscle mass
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
